コメントを投稿するにはログインが必要です
ログインページへ記事ができると、章ごとの要約と、聴きどころへ飛べる目次がここに並びます。いまは音声で聴けます。
#6-26E. Navigating Antiphospholipid Syndrome: Diagnosis, Risk Stratification, and Management (NEJM, 2018)
2026年11月14日 12:00·6分7秒
How can clinicians accurately diagnose and manage antiphospholipid syndrome while avoiding common pitfalls of misdiagnosis? This review highlights the critical role of verifying persistent, high-risk antiphospholipid antibody profiles at least 12 weeks apart to guide tailored treatment for thrombotic and obstetrical events. While many recommendations rely heavily on expert opinion rather than robust randomized trials, understanding these antibody profiles enables precise risk stratification. Ultimately, this consensus helps physicians deliver targeted antithrombotic management, improving clinical outcomes across diverse patient presentations.
Citation: Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. The New England Journal of Medicine. 2018.
DOI: 10.1056/NEJMra1705454
Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.
